1322 Too sweet to be true: sucralose ablates immunotherapy response through microbiome disruption
Main Authors: | Jishnu Das, Greg Delgoffe, Diwakar Davar, Stacy Wendell, Hector Nieves-Rosado, Bingxian Xie, Kristin Morder, Abigail E Overacre-Delgoffe, Drew Wilfahrt, Douglas Prado, Madison Nguyen, William Hawse, Larry Kane |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
1320 Helicobacter hepaticus colonization endows immunotherapeutic sensitivity in refractory melanoma tumors
by: Jessica Jana, et al.
Published: (2023-11-01) -
1323 Changes in the microbiome after treatment: are we setting colorectal cancer patients back before they begin?
by: Jessica Jana, et al.
Published: (2023-11-01) -
944 Obese, not starving: mitochondrial citrate export drives lipid accumulation and dysfunction in exhausted T cells
by: Nicole Scharping, et al.
Published: (2023-11-01) -
Mouse innate resistance to Neospora caninum infection is driven by early production of IFNγ by NK cells in response to parasite ligands
by: R. S. Coombs, et al.
Published: (2024-11-01) -
273 Hypermetabolic expansion conditions imprint lasting dysfunction on adoptive cell therapies
by: Greg Delgoffe, et al.
Published: (2023-11-01)